263 related articles for article (PubMed ID: 29229835)
1.
Wang Y; Liu J; Jin X; Zhang D; Li D; Hao F; Feng Y; Gu S; Meng F; Tian M; Zheng Y; Xin L; Zhang X; Han X; Aravind L; Wei M
Proc Natl Acad Sci U S A; 2017 Dec; 114(52):13732-13737. PubMed ID: 29229835
[TBL] [Abstract][Full Text] [Related]
2. Alteration of O-GlcNAcylation affects serine phosphorylation and regulates gene expression and activity of pyruvate kinase M2 in colorectal cancer cells.
Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V
Oncol Rep; 2015 Oct; 34(4):1933-42. PubMed ID: 26252736
[TBL] [Abstract][Full Text] [Related]
3. EGF promotes PKM2 O-GlcNAcylation by stimulating O-GlcNAc transferase phosphorylation at Y976 and their subsequent association.
Wang Y; Shu H; Liu J; Jin X; Wang L; Qu Y; Xia M; Peng P; Feng Y; Wei M
J Biol Chem; 2022 Sep; 298(9):102340. PubMed ID: 35931120
[TBL] [Abstract][Full Text] [Related]
4. ULK1-dependent phosphorylation of PKM2 antagonizes O-GlcNAcylation and regulates the Warburg effect in breast cancer.
Zhou Z; Zheng X; Zhao J; Yuan A; Lv Z; Shao G; Peng B; Dong MQ; Xu Q; Xu X; Li J
Oncogene; 2024 Apr; ():. PubMed ID: 38632437
[TBL] [Abstract][Full Text] [Related]
5. Estradiol-17β upregulates pyruvate kinase M2 expression to coactivate estrogen receptor-α and to integrate metabolic reprogramming with the mitogenic response in endometrial cells.
Salama SA; Mohammad MA; Diaz-Arrastia CR; Kamel MW; Kilic GS; Ndofor BT; Abdel-Baki MS; Theiler SK
J Clin Endocrinol Metab; 2014 Oct; 99(10):3790-9. PubMed ID: 24471565
[TBL] [Abstract][Full Text] [Related]
6. Signal transducer and activator of transcription 3 promotes the Warburg effect possibly by inducing pyruvate kinase M2 phosphorylation in liver precancerous lesions.
Bi YH; Han WQ; Li RF; Wang YJ; Du ZS; Wang XJ; Jiang Y
World J Gastroenterol; 2019 Apr; 25(16):1936-1949. PubMed ID: 31086462
[TBL] [Abstract][Full Text] [Related]
7. Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth.
Hitosugi T; Kang S; Vander Heiden MG; Chung TW; Elf S; Lythgoe K; Dong S; Lonial S; Wang X; Chen GZ; Xie J; Gu TL; Polakiewicz RD; Roesel JL; Boggon TJ; Khuri FR; Gilliland DG; Cantley LC; Kaufman J; Chen J
Sci Signal; 2009 Nov; 2(97):ra73. PubMed ID: 19920251
[TBL] [Abstract][Full Text] [Related]
8. Pyruvate kinase M2 affects liver cancer cell behavior through up-regulation of HIF-1α and Bcl-xL in culture.
Dong T; Yan Y; Chai H; Chen S; Xiong X; Sun D; Yu Y; Deng L; Cheng F
Biomed Pharmacother; 2015 Feb; 69():277-84. PubMed ID: 25661370
[TBL] [Abstract][Full Text] [Related]
9. Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells.
Mazurek S
Int J Biochem Cell Biol; 2011 Jul; 43(7):969-80. PubMed ID: 20156581
[TBL] [Abstract][Full Text] [Related]
10. Glucose restriction reverses the Warburg effect and modulates PKM2 and mTOR expression in breast cancer cell lines.
Tahtouh R; Wardi L; Sarkis R; Hachem R; Raad I; El Zein N; Hilal G
Cell Mol Biol (Noisy-le-grand); 2019 Sep; 65(7):26-33. PubMed ID: 31880514
[TBL] [Abstract][Full Text] [Related]
11. [Novel mechanism for invasion and metastasis involving metabolic enzymes in intractable cancer cells].
Konno M; Hamabe A; Doki Y; Mori M; Ishii H
Rinsho Ketsueki; 2015 Aug; 56(8):1059-63. PubMed ID: 26345567
[TBL] [Abstract][Full Text] [Related]
12. Pyruvate kinase M2 regulates glucose metabolism by functioning as a coactivator for hypoxia-inducible factor 1 in cancer cells.
Luo W; Semenza GL
Oncotarget; 2011 Jul; 2(7):551-6. PubMed ID: 21709315
[TBL] [Abstract][Full Text] [Related]
13. ECM1 promotes the Warburg effect through EGF-mediated activation of PKM2.
Lee KM; Nam K; Oh S; Lim J; Lee T; Shin I
Cell Signal; 2015 Feb; 27(2):228-35. PubMed ID: 25446258
[TBL] [Abstract][Full Text] [Related]
14. 1-(sulfonyl)-5-(arylsulfonyl)indoline as activators of the tumor cell specific M2 isoform of pyruvate kinase.
Yacovan A; Ozeri R; Kehat T; Mirilashvili S; Sherman D; Aizikovich A; Shitrit A; Ben-Zeev E; Schutz N; Bohana-Kashtan O; Konson A; Behar V; Becker OM
Bioorg Med Chem Lett; 2012 Oct; 22(20):6460-8. PubMed ID: 22963766
[TBL] [Abstract][Full Text] [Related]
15. Pyruvate kinase M2: multiple faces for conferring benefits on cancer cells.
Tamada M; Suematsu M; Saya H
Clin Cancer Res; 2012 Oct; 18(20):5554-61. PubMed ID: 23071357
[TBL] [Abstract][Full Text] [Related]
16. HSP40 interacts with pyruvate kinase M2 and regulates glycolysis and cell proliferation in tumor cells.
Huang L; Yu Z; Zhang T; Zhao X; Huang G
PLoS One; 2014; 9(3):e92949. PubMed ID: 24658033
[TBL] [Abstract][Full Text] [Related]
17. Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancer.
Chao TK; Huang TS; Liao YP; Huang RL; Su PH; Shen HY; Lai HC; Wang YC
PLoS One; 2017; 12(7):e0182166. PubMed ID: 28753677
[TBL] [Abstract][Full Text] [Related]
18. Isoform switch of pyruvate kinase M1 indeed occurs but not to pyruvate kinase M2 in human tumorigenesis.
Zhan C; Yan L; Wang L; Ma J; Jiang W; Zhang Y; Shi Y; Wang Q
PLoS One; 2015; 10(3):e0118663. PubMed ID: 25738776
[TBL] [Abstract][Full Text] [Related]
19. The Warburg Effect Mediator Pyruvate Kinase M2 Expression and Regulation in the Retina.
Rajala RV; Rajala A; Kooker C; Wang Y; Anderson RE
Sci Rep; 2016 Nov; 6():37727. PubMed ID: 27883057
[TBL] [Abstract][Full Text] [Related]
20. Role in post
Pan T; Hao J; Wang Y; Duan W; Yue L; Gao X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Sept 28; 48(9):1359-1367. PubMed ID: 38044647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
